NVO - WHO warns on fake versions of Novo Nordisk's Ozempic
2024-06-20 15:09:50 ET
More on Novo Nordisk
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
- Novo reports new fire at Danish site; third in a month
- Eli Lilly oral weight-loss candidate orforglipron is potential winner: SA Investing Summit